(Q37983096)

26 August 2017

title

IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential (English)

1 reference

26 August 2017

1 reference

Shu Zhu

1

1 reference

26 August 2017

Youcun Qian

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

122

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

487-511

1 reference

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A pathogenic role of IL- 17 at the early stage of corneal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Obesity predisposes to Th17 bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Endogenous IL-17 contributes to reduced tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 and its expanding biological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The role of the novel Th17 cytokine IL-26 in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Genomic structure and chromosomal mapping of the nuclear orphan receptor ROR gamma (RORC) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Transcriptional regulation of the Th17 immune response by IKK(alpha)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Ets-1 is a negative regulator of Th17 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

STAT3 mutations in the hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

TGF-beta promotes Th17 cell development through inhibition of SOCS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Fate mapping of IL-17-producing T cells in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Effector T cell plasticity: flexibility in the face of changing circumstances

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Structure and signalling in the IL-17 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The STIR-domain superfamily in signal transduction, development and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Structural basis of receptor sharing by interleukin 17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 enhances chemokine gene expression through mRNA stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Act1, an NF-kappa B-activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

CIKS, a connection to Ikappa B kinase and stress-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Act1, a negative regulator in CD40- and BAFF-mediated B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IMMUNOLOGY:Enhanced: Defensins and Host Defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Immunogenic and tolerogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Autoreactive T cells as potential targets for immunotherapy of autoimmune bullous skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Speculations on Mechanisms of HLA Associations with Autoimmune Diseases and the Specificity of "Autoreactive" T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Etiologic factors and pathogenetic aspects of organ-specific autoimmune diseases. Essential role of autoreactive T cells and lymphokine network in the activation of effector systems responsible for tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 and Th17 cells in human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 signaling in host defense and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Evolving concepts of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Th17 cell differentiation: the long and winding road

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 induces monocyte migration in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The role of interleukin-17 in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 as a future therapeutic target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The IL-17 pathway as a major therapeutic target in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Regulation of inflammatory responses by IL-17F

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17 in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Pathogenesis of human systemic lupus erythematosus: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The role of IL-23/IL-17 axis in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-23 drives pathogenic IL-17-producing CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Actual status of antiinterleukin-1 therapies in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Functional specialization of interleukin-17 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IL-17C regulates the innate immune function of epithelial cells in an autocrine manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

IκBζ regulates TH17 development by cooperating with ROR nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110496

21 January 2018

Identifiers

DOI

10.1042/CS20110496

1 reference

26 August 2017

1 reference